Aethlon Medical Inc (NASDAQ:AEMD) — Market Cap & Net Worth
Market Cap & Net Worth: Aethlon Medical Inc (AEMD)
Aethlon Medical Inc (NASDAQ:AEMD) has a market capitalization of $2.51 Million ($2.51 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29704 globally and #5988 in its home market, demonstrating a -1.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aethlon Medical Inc's stock price $1.91 by its total outstanding shares 1315110 (1.32 Million). Review Aethlon Medical Inc (AEMD) total liabilities to assess the company's total debt and financial obligations.
Aethlon Medical Inc Market Cap History: 2015 to 2026
Aethlon Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $1.34 Billion to $2.51 Million (-44.59% CAGR).
Index Memberships
Aethlon Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #881 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2797 of 3165 |
Weight: Aethlon Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aethlon Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aethlon Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.02x
Aethlon Medical Inc's market cap is 5.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $828.52 Million | $886.57K | -$4.87 Million | 934.52x | N/A |
| 2017 | $222.91 Million | $392.07K | -$7.28 Million | 568.55x | N/A |
| 2018 | $327.46 Million | $149.62K | -$5.68 Million | 2188.55x | N/A |
| 2019 | $12.66 Million | $229.62K | -$6.20 Million | 55.15x | N/A |
| 2020 | $32.48 Million | $650.19K | -$6.37 Million | 49.96x | N/A |
| 2021 | $24.46 Million | $659.10K | -$7.85 Million | 37.11x | N/A |
| 2022 | $3.62 Million | $294.17K | -$10.42 Million | 12.31x | N/A |
| 2023 | $2.88 Million | $574.25K | -$12.03 Million | 5.02x | N/A |
Competitor Companies of AEMD by Market Capitalization
Companies near Aethlon Medical Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Aethlon Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Aethlon Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Aethlon Medical Inc's market cap moved from $1.34 Billion to $ 2.51 Million, with a yearly change of -44.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.51 Million | -31.05% |
| 2025 | $3.64 Million | +222.09% |
| 2024 | $1.13 Million | -60.73% |
| 2023 | $2.88 Million | -20.48% |
| 2022 | $3.62 Million | -85.19% |
| 2021 | $24.46 Million | -24.70% |
| 2020 | $32.48 Million | +156.49% |
| 2019 | $12.66 Million | -96.13% |
| 2018 | $327.46 Million | +46.90% |
| 2017 | $222.91 Million | -73.10% |
| 2016 | $828.52 Million | -38.14% |
| 2015 | $1.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Aethlon Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.51 Million USD |
| MoneyControl | $2.51 Million USD |
| MarketWatch | $2.51 Million USD |
| marketcap.company | $2.51 Million USD |
| Reuters | $2.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Di… Read more